Ercros (CHIX:ECRE) YoY EBITDA Growth: 1,247.06% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:ECRE Ercros SA CHIX:ECRE
65 GF Score
Price €3.40
GF Value €3.11
! 7 Warning Signs
View Full Analysis

What is Ercros YoY EBITDA Growth?

Ercros CHIX:ECRE 65 YoY EBITDA Growth is 1,247.06% as of Jun. 2026. GuruFocus rates CHIX:ECRE with a GF Score™ of 65/100 and a GF Value™ of €3.11. The stock has 7 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Ercros's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 1,247.06%.

Ercros's EBITDA per Share for the three months ended in Jun. 2026 was €0.20.

Ercros YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Ercros's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ercros YoY EBITDA Growth Chart

Ercros Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 119.51 37.44 -62.65 -38.74 -100.35

Ercros Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -134.00 48.65 -213.51 -466.67 1,247.06
CHIX:ECRE
65GF Score
Ercros SA CHIX:ECRE
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ercros YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Ercros's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(-0.001-0.283)/ | 0.283 |
=-100.35 %

Ercros's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(0.195--0.017)/ | -0.017 |
=1,247.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 1,247.06% mean?
Ercros (CHIX:ECRE) has a YoY EBITDA Growth of 1,247.06% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Ercros and its competitors.
Is Ercros' YoY EBITDA Growth too high?
Ercros' current YoY EBITDA Growth is 1,247.06%. Overall, Ercros has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does Ercros' YoY EBITDA Growth compare to DOW?
Ercros' YoY EBITDA Growth of 1,247.06% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Chemicals company?
A good YoY EBITDA Growth depends on the Chemicals industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Ercros and its competitors. Ercros's current YoY EBITDA Growth is 1,247.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ercros stock overvalued right now?
Ercros (CHIX:ECRE) has a current YoY EBITDA Growth of 1,247.06%. The stock's GF Value™ is €3.11, compared to a current price of €3.40 — trading 9.2% above its estimated fair value. The current YoY EBITDA Growth is 1,247.06%. Ercros' overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Ercros (CHIX:ECRE), the current YoY EBITDA Growth is 1,247.06% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ercros (CHIX:ECRE) Overvalued in 2026?

Based on GuruFocus' analysis, Ercros stock appears to be overvalued. The current stock price of €3.40 is trading 9.2% above its estimated GF Value™ of €3.11.

Key valuation signals for CHIX:ECRE:

  • YoY EBITDA Growth: 1,247.06%
  • GF Value™: €3.11 vs. price of €3.40 (9.2% above fair value)
  • GF Score™: 65/100 with 7 warning signs

No single metric tells the full story. See the CHIX:ECRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ercros Business Description

Address Avinguda Diagonal, 593-595, Barcelona, ESP, 08014
Ercros SA is a chemical manufacturing company operating in basic and plastic chemicals divisions, intermediate chemicals division, and pharmaceuticals division. The company's product portfolio includes Caustic soda, Hydrochloric acid, Sodium chloride, Sodium hypochlorite, Glues and resins, Moulding compounds, Pentaerythritol, Erythromycin, Fosfomycin, Fusidic acid, among others. Its products are supplied to various industries including the chemical industry, construction, wood industry, paints, food industry, pharmaceuticals, electric material, and water treatment. The majority of the revenue is derived from the sale of basic chemicals in the local markets.
65GF Score

Get the complete analysis for CHIX:ECRE

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.40
Price
€3.11
GF Value